Acura Pharmaceutical Provides Development Update on its LIMITx(TM) Technology
PALATINE, IL--(Marketwired - December 14, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the U.S. Food and Drug Administration (FDA) has provided the Company …